Crimson Capital is part of a Chemonics-led consortium recently awarded the USAID Asia and Middle East Economic Growth (AMEG) contract, designed to support policy and institutional reforms leading to expanded trade and investment, broad-based economic growth and poverty reduction in the region. Task Orders issued through AMEG will focus on identifying and promoting best practices in economic growth and supporting economic and financial analysis, program design and assessment.